Valuing an ABA (Applied Behavior Analysis) therapy practice requires understanding the operational and clinical drivers acquirers care about — and they're not session count or office square footage. The first step is calculating accurate EBITDA and seller's discretionary earnings (SDE). EBITDA strips away financing and tax decisions to show operating profit; SDE adds back owner-clinician benefits including salary, vehicle, and discretionary expenses only one owner-operator incurs. For ABA practices, SDE typically ranges from 2.0x–3.5x and EBITDA from 6x–9x, with the upper end reserved for multi-location practices with strong BCBA leverage and diversified payer mix.

First, assess your BCBA-to-RBT leverage ratio. The clinical economics of ABA depend entirely on the ratio of Board Certified Behavior Analysts (BCBAs) to Registered Behavior Technicians (RBTs). Industry benchmarks sit at 1 BCBA per 8–10 RBTs. Practices achieving 1:10 or higher demonstrate operational efficiency and margin leverage that buyers reward with premium multiples. Lower ratios (1:5 or 1:6) suggest underutilized BCBA time and cap your EBITDA potential. Document your BCBA staffing ratio, RBT utilization, and the productive-hour conversion rate. Strategic acquirers like Behavior Frontiers, Hopebridge, Centria Healthcare, and Cortica specifically diligence this ratio.

Second, audit payer mix and Medicaid exposure. Payer mix is the single largest determinant of margin profile in ABA. Practices with 60%+ commercial insurance revenue typically earn 25%+ EBITDA margins, while Medicaid-dependent practices in low-rate states (where rates run $40–$55/hour) struggle to clear 12–15% margins. Buyers want to see commercial insurance contracts with major payers (Aetna, Anthem, BCBS, Cigna, UnitedHealth) at the contracted rate, plus a manageable Medicaid percentage in higher-rate states. Document your payer mix by revenue, your average reimbursement rate per hour, and your prior-authorization approval rates.

Third, evaluate authorization rates and revenue cycle metrics. ABA revenue is gated by prior authorizations, which can take weeks to obtain and frequently get partially approved. Practices achieving 95%+ first-pass authorization approval and 90%+ billed-to-collected ratios demonstrate operational maturity and revenue predictability. Practices with 70–80% approval rates and chronic A/R aging suggest weak intake and billing processes that depress valuation. Document your prior-auth approval rates, denial reasons, days in A/R, and write-off percentages.

Fourth, scrutinize clinical quality and outcome measurement. Top buyers increasingly require evidence-based outcome data — PEAK, VB-MAPP, ABLLS-R, Vineland — to validate that the practice delivers clinical results. Practices that systematically measure goals, document progress, and share outcomes with families and payers command premiums because their clinical model is defensible to insurers and acquirers. Document your assessment frequency, goal-mastery rates, and parent satisfaction metrics (NPS or CAHPS-style).

Fifth, examine RBT retention and staffing model. ABA's number-one operational headache is RBT turnover, which industry-wide runs 50–70% annually. Practices with sub-30% RBT turnover demonstrate strong supervisory culture, training programs, and career-pathing — all of which signal operational stability to acquirers. Document your turnover by year, average RBT tenure, and your training/credentialing pipeline. Practices with internal RBT-to-BCBA development programs reduce buyer integration risk and earn premiums.

Sixth, evaluate geographic footprint and multi-location scalability. Single-location practices command 6x–7x EBITDA. Multi-location practices with 3–8 sites and proven repeatable operations earn 7x–9x EBITDA because they prove the model scales. Document your location performance metrics, your operational playbook, and your hiring and onboarding systems. Multi-state operators face additional licensing complexity but earn premium multiples when they demonstrate compliance maturity.

Specific buyer types approach ABA acquisitions differently. Strategic acquirers (Behavior Frontiers, Hopebridge, Centria Healthcare, Cortica, ABA Centers of America) buy regional practices for geographic expansion and BCBA capacity. PE platforms (Audax, FFL Partners, Council Capital) build multi-state ABA platforms — ABA is one of the most active healthcare-services consolidation categories in the U.S. Specialty buyers in autism schools, diagnostic services, and pediatric therapy networks pay premiums for integrated-care capability.

Practical 18-month playbook to lift your multiple. Months 1-3: pull your operational scorecard — BCBA-to-RBT ratio by site, payer mix by revenue, prior-auth approval rates, denial reasons, RBT turnover by year, and clinical outcome data. Months 4-9: improve BCBA leverage by hiring or upskilling RBTs to bring the ratio toward 1:9 or 1:10. Months 6-12: contract with one or two additional commercial payers (Aetna, BCBS, Cigna, UnitedHealth) and shift payer mix toward 60%+ commercial revenue. Months 9-15: formalize outcome measurement using PEAK, VB-MAPP, or Vineland and start sharing results with families and payers. Months 12-18: tighten RBT retention with career-pathing, supervision-hour tracking, and BCBA-development pipelines. Months 15-18: package payer contracts, clinical outcome reports, location-level financials, and your scaling playbook for diligence. Done well, this playbook moves a $5M-revenue practice from a 6x EBITDA offer to 8x — adding $2M-$4M of enterprise value at exit. Related industries that follow similar consolidation dynamics include Mental Health Practice, Behavioral Health / Addiction Treatment, and Dental Practice.